AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Galacto-Oligosaccharide Market to Grow by 498.15 Million During 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. and Clasado BioSciences | Technavio

January 6, 2020 GMT
Global Galacto-Oligosaccharide Market to Grow by 498.15 Million During 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. and Clasado BioSciences | Technavio
Global Galacto-Oligosaccharide Market to Grow by 498.15 Million During 2020-2024 | Evolving Opportunities with Baolingbao Biology Co. Ltd. and Clasado BioSciences | Technavio

LONDON--(BUSINESS WIRE)--Jan 6, 2020--

The galacto-oligosaccharide market size is expected to grow by USD 498.15 million during 2020-2024, according to the latest market research report by Technavio, progressing at a CAGR of close to 10% during the forecast period. Market growth can be attributed to the health benefits of galacto-oligosaccharide. Furthermore, the increasing need for supplementary nutrients among infants and the growing popularity of e-commerce in the healthcare industry are other factors that will drive the galacto-oligosaccharide market during the forecast period. Request a free sample report

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106005078/en/

Technavio has announced its latest market research report titled global galacto-oligosaccharide market 2020-2024. (Graphic: Business Wire)

Read the 139-page report with TOC on “Galacto-Oligosaccharide Market by Product (syrup and powder), Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts, 2020-2024”.

Galacto-Oligosaccharide Product Outlook (Revenue, USD Million, 2020-2024)

The syrup segment held a significant share of the galacto-oligosaccharide market in 2019 because the syrup form is preferred over powder form as it dissolves easily and can be mixed with food products. However, galacto-oligosaccharide powder is preferred for use in dairy products, food supplements, beverages, confectionery, and more, which is expected to augment the growth of the powder segment during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Galacto-Oligosaccharide Regional Outlook (Revenue, USD Million, 2020-2024)

The European region led the market in 2019, followed by North America, Asia, and ROW, respectively. The growth of the galacto-oligosaccharide market share in Europe can be attributed to several factors such as the rising sales of prebiotic foods, and the increase in disposable income of consumers in the region.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Major Five Galacto-Oligosaccharide Companies:

Baolingbao Biology Co. Ltd.

Baolingbao Biology Co. Ltd. has business operations under various segments, which include oligosaccharides series, fructose series, dietary fiber, starch sugar, feed series, and others. The company offers galacto-oligosaccharides in the powder and syrup form to the food and beverage, animal feed, pharmaceutical, and personal care sectors.

Clasado BioSciences

Clasado BioSciences develops and manufactures advanced galacto-oligosaccharide products for the food, healthcare, and pharmaceutical companies in the global wellness market. The company’s offerings include Bimuno, a daily fiber supplement containing galacto-oligosaccharides, which feeds and stimulates the growth of good bacteria in the gut.

Fonterra Co-operative Group Ltd.

Fonterra Co-operative Group Ltd. operates under three segments, namely ingredients, consumer and foodservice, and china farms. The company’s key offerings include NZMP SureStart GOS. It is a prebiotic supplement added to infant formula products to make them closer to the composition of breast milk for mothers who cannot or choose not to breastfeed. The SureStart galacto-oligosaccharide is available as GOS 57 Syrup, GOS 70 Syrup, and powder.

Ingredion Inc.

Ingredion Inc. has business operations in various geographic segments, including North America, South America, APAC, and EMEA. The company’s key offerings include BIOLIGO GL 5700 IMF, which is a soluble dietary fiber made from lactose in the form of a syrup that contains 57% galacto-oligosaccharide (dry basis).

Lactose (India) Ltd.

Lactose (India) Ltd. is engaged in the business of manufacturing and trading of pharmaceutical products. The company offers Prebiotic-galacto-oligosaccharide, which is produced through the enzymatic conversion of lactose and is available in the powder form.

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200106005078/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 01/06/2020 06:15 AM/DISC: 01/06/2020 06:15 AM

http://www.businesswire.com/news/home/20200106005078/en